TOP TIERMARKET NEWSWIRE

News & sentiment

ZYMEWORKS INC (ZYME) — News & AI sentiment

ZYMEWORKS INC (ZYME) news roundup. 4 stories in the past week, 21 over 30 days. Average 30-day sentiment is 62.1/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

4

avg sentiment 58.5/100

30d stories

21

avg sentiment 62.1/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

ZYME news in the last 24 hours, 7 days, 30 days and 90 days

How much ZYME coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	ZYME stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	4	58.5/100	ZYME headlines →
Last 30 days	21	62.1/100	ZYME headlines →
Last 90 days	51	59.2/100	ZYME headlines →

Latest stories on ZYME

Zymeworks' Theravance Deal Is A Breath Of Fresh Cash Flow

Seeking Alpha67 · bullishm&a

1d ago

3 things to look out for on Friday

Seeking Alpha50 · neutralgeneral

2d ago

Zymeworks initiated with an Outperform at Wolfe Research

The Fly61 · neutralanalyst

2d ago

Zymeworks Inc. (ZYME) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha56 · neutralgeneral

5d ago

Zymeworks price target raised to $33 from $31 at JPMorgan

The Fly61 · neutralanalyst

Sep 3

Zymeworks options signal bullish surge as $35 September calls dominate

Investing.com Markets63 · neutralgeneral

Aug 31

Zymeworks: Transitioning Into A Royalty-Driven Biopharma Platform Post Ziihera Approval

Seeking Alpha67 · bullishproduct/pr

Aug 27

SJM, ZYME Stocks Hit 52-Week High – What’s Driving The Surge Today?

Stocktwits News67 · bullishearnings

Aug 26

FDA Approval of Ziihera Ushers in New Era for Zymeworks: $250M Windfall, Expanded Royalties, and Strengthened Oncology Pipeline August 26, 2026

MarketChameleon73 · bullishproduct/pr

Aug 26

Zymeworks moves higher as Street cheers Ziihera regimen approval

Seeking Alpha73 · bullishgeneral

Aug 26

H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval

Investing.com Analyst Ratings61 · neutralanalyst

Aug 26

Zymeworks price target raised to $38 from $37 at Citi

The Fly61 · neutralanalyst

Aug 26

Zymeworks price target raised to $55 from $51 at H.C. Wainwright

The Fly61 · neutralanalyst

Aug 26

Zymeworks stock rating reiterated at Market Outperform by Citizens

Investing.com Analyst Ratings56 · neutralanalyst

Aug 26

JAZZ, ONC, ZYME Stocks In Focus After FDA Approves Gastroesophageal Cancer Therapy

Stocktwits News67 · bullishproduct/pr

Aug 25

Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens

TipRanks68 · bullishproduct/pr

Aug 25

Zymeworks Inc. (ZYME) files 8-K

SEC 8-K50 · neutralgeneral

Aug 25

Zymeworks says partner Jazz receives FDA approval for Ziihera regimens

The Fly67 · bullishproduct/pr

Aug 25

Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab

InvestorsHub63 · neutralgeneral

Aug 24

Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab

Yahoo Finance63 · neutralproduct/pr

Aug 24

Why is Zymeworks stock surging today?

Investing.com Markets50 · neutralgeneral

Aug 24

Zymeworks Announces Participation in Upcoming Investor Conferences

Business Insider56 · neutralgeneral

Aug 11

Zymeworks gains following addition to Citi catalyst watch

Seeking Alpha63 · neutralanalyst

Aug 10

Zymeworks Price Target Raised To 44 From 40 At B Riley

The Fly61 · neutralanalyst

Aug 10

Citi Adds Upside 90 Day Catalyst Watch On Zymeworks In Fda Decision

The Fly56 · neutralanalyst

Aug 10

Open ZYME in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →